BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17804093)

  • 1. The transcriptional repression by NIPP1 is mediated by Polycomb group proteins.
    Roy N; Van Eynde A; Beke L; Nuytten M; Bollen M
    Biochim Biophys Acta; 2007; 1769(9-10):541-5. PubMed ID: 17804093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.
    Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M
    Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets.
    Van Dessel N; Beke L; Görnemann J; Minnebo N; Beullens M; Tanuma N; Shima H; Van Eynde A; Bollen M
    Nucleic Acids Res; 2010 Nov; 38(21):7500-12. PubMed ID: 20671031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein phosphatase-1 (PP1) regulator, nuclear inhibitor of PP1 (NIPP1), interacts with the polycomb group protein, embryonic ectoderm development (EED), and functions as a transcriptional repressor.
    Jin Q; van Eynde A; Beullens M; Roy N; Thiel G; Stalmans W; Bollen M
    J Biol Chem; 2003 Aug; 278(33):30677-85. PubMed ID: 12788942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.
    Attwooll C; Oddi S; Cartwright P; Prosperini E; Agger K; Steensgaard P; Wagener C; Sardet C; Moroni MC; Helin K
    J Biol Chem; 2005 Jan; 280(2):1199-208. PubMed ID: 15536069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes.
    Minnebo N; Görnemann J; O'Connell N; Van Dessel N; Derua R; Vermunt MW; Page R; Beullens M; Peti W; Van Eynde A; Bollen M
    Nucleic Acids Res; 2013 Jan; 41(2):842-54. PubMed ID: 23241245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins.
    Zoabi M; Sadeh R; de Bie P; Marquez VE; Ciechanover A
    Biochem Biophys Res Commun; 2011 May; 408(3):393-8. PubMed ID: 21513699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Polycomb group protein EZH2 directly controls DNA methylation.
    Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
    Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.
    Hwang C; Giri VN; Wilkinson JC; Wright CW; Wilkinson AS; Cooney KA; Duckett CS
    Breast Cancer Res Treat; 2008 Jan; 107(2):235-42. PubMed ID: 17453341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.
    Boulay G; Dubuissez M; Van Rechem C; Forget A; Helin K; Ayrault O; Leprince D
    J Biol Chem; 2012 Mar; 287(13):10509-10524. PubMed ID: 22315224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced NIPP1 activation enhances metastatic potential and predicts poor prognosis in hepatocellular carcinoma.
    Huang Y; Tao Y; Hu K; Lin F; Li X; Feng T; Wang ZM
    Tumour Biol; 2016 Nov; 37(11):14903-14914. PubMed ID: 27644248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
    Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
    Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
    Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
    J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
    Yonemitsu Y; Imazeki F; Chiba T; Fukai K; Nagai Y; Miyagi S; Arai M; Aoki R; Miyazaki M; Nakatani Y; Iwama A; Yokosuka O
    Hum Pathol; 2009 Sep; 40(9):1304-11. PubMed ID: 19386347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
    Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
    Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for transmission of the H3K27me3 epigenetic mark.
    Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
    Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.
    Sarma K; Margueron R; Ivanov A; Pirrotta V; Reinberg D
    Mol Cell Biol; 2008 Apr; 28(8):2718-31. PubMed ID: 18285464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.